Back to Type 2 Diabetes
NCT00613782
NCT00613782
Who may be able to join
Who might be able to join this trial:
- You have been diagnosed with Type 2 diabetes
- Your testosterone level is below a certain low level (less than 10 nmol/L — confirm with trial site for what this means for you)
Who may not be able to join:
- You have a medical reason why you cannot take testosterone (confirm with trial site)
- You have a medical reason why you cannot receive injections into the muscle (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Trial details
Status
Completed
Phase
Phase 3
Sponsor
Austin Health
Registry
clinicaltrials_gov
Start date
1 January 2009
Est. completion
1 January 2014
Where this trial is recruiting
🇦🇺 Australia
1 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Insulin Resistance
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.